Cargando…

Clinical Trial Comparing the Efficacy and Safety of Regional Citrate Anticoagulation Versus Heparin in CRRT

INTRODUCTION: Heparin continues to be the most common modality of anticoagulation in CRRT. The increased risk of hemorrhagic complications associated with its use led to the emergence of regional citrate anticoagulation (RCA) as an alternative. However, the perceived complexities associated with its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Senthilkumar, S, Sampathkumar, Krishnaswamy, Rajiv, Andrew Deepak, Dwarak, S, Harsha, H B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503585/ https://www.ncbi.nlm.nih.gov/pubmed/37781556 http://dx.doi.org/10.4103/ijn.ijn_169_22

Ejemplares similares

Citrate Anticoagulation for CRRT in Children: Comparison with Heparin
por: Fernández, Sara Nicole, et al.
Publicado: (2014)

Simplified Citrate Anticoagulation for CRRT Without Calcium Replacement
por: Broman, Marcus, et al.
Publicado: (2015)

Preventing continuous renal replacement therapies (CRRT)-induced hypophosphatemia using a phosphate-containing CRRT solution in the setting of regional citrate anticoagulation
por: Pistolesi, V, et al.
Publicado: (2014)

Citrate anticoagulation for CRRT: don’t always trust the postfilter iCa results!
por: Oudemans-van Straaten, Heleen M., et al.
Publicado: (2015)

Ionized calcium measurements during regional citrate anticoagulation in CRRT: we need better blood gas analyzers
por: Kindgen-Milles, Detlef, et al.
Publicado: (2015)

Blood transfusion requirements and filter longevity with regional citrate anticoagulation compared with heparin
por: Burford, E, et al.
Publicado: (2015)

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care
por: Doidge, James C., et al.
Publicado: (2023)

Discrepant post filter ionized calcium concentrations by common blood gas analyzers in CRRT using regional citrate anticoagulation
por: Schwarzer, Patrik, et al.
Publicado: (2015)

Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk
por: Jiao, Jing, et al.
Publicado: (2023)

A novel citrate-based protocol versus heparin anticoagulation for sustained low-efficiency dialysis in the ICU: safety, efficacy, and cost
por: Wen, Ming, et al.
Publicado: (2018)

Blood epuration of middle molecules in continuous venovenous hemodiafiltration with regional citrate anticoagulation versus systemic heparinization
por: Nogier, MB, et al.
Publicado: (2009)

Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
por: Raymakers-Janssen, Paulien A. M. A., et al.
Publicado: (2017)

Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit
por: Davenport, Andrew, et al.
Publicado: (2009)

Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT
por: Thanapongsatorn, Peerapat, et al.
Publicado: (2022)

Heparin-free regional anticoagulation of haemodialysis filters with calcium-free dialysate: is citrate mandatory?
por: Medrano, Chloé, et al.
Publicado: (2021)

Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011)

Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study
por: Yu, Yan, et al.
Publicado: (2020)

Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2011)

Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
por: Slowinski, Torsten, et al.
Publicado: (2015)

Regional Citrate Anticoagulation or Heparin Anticoagulation for Renal Replacement Therapy in Patients With Liver Failure: A Systematic Review and Meta-Analysis
por: Qi, Wenqian, et al.
Publicado: (2023)

Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation
por: Margraf, Andreas, et al.
Publicado: (2022)

Multicenter prospective observational study on safety and efficacy of regional citrate anticoagulation in CVVHD in the presence of liver failure: the Liver Citrate Anticoagulation Threshold Study (L-CAT)
por: Slowinski, T, et al.
Publicado: (2011)

Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial
por: Stucker, Fabien, et al.
Publicado: (2015)

Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO
por: Streng, Alexander S., et al.
Publicado: (2020)

Comparative effectiveness and safety of anticoagulants for the treatment of heparin‐induced thrombocytopenia
por: Nilius, Henning, et al.
Publicado: (2021)

Complications of regional citrate anticoagulation: accumulation or overload?
por: Schneider, Antoine G., et al.
Publicado: (2017)

Regional Citrate Anticoagulation for Intermittent Hemodialysis in Dogs
por: Francey, T., et al.
Publicado: (2017)

Regional citrate anticoagulation in hemodialysis: an observational study of safety, efficacy, and effect on calcium balance during routine care
por: Singer, Richard F., et al.
Publicado: (2016)

Safety and efficacy of regional citrate anticoagulation in continuous blood purification treatment of patients with multiple organ dysfunction syndrome
por: Tuerdi, B., et al.
Publicado: (2017)

Comparison between regional citrate anticoagulation and heparin for intermittent hemodialysis in ICU patients: a propensity score-matched cohort study
por: Leroy, Christophe, et al.
Publicado: (2021)

Early mortality on continuous renal replacement therapy (CRRT): the prairie CRRT study
por: Prasad, Bhanu, et al.
Publicado: (2016)

Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation
por: Kozik-Jaromin, Justyna, et al.
Publicado: (2009)

Impact of anion exchange adsorbents on regional citrate anticoagulation
por: Strobl, Karin, et al.
Publicado: (2020)

Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
por: Liu, Chao, et al.
Publicado: (2016)

A mode of CVVH with regional citrate anticoagulation compared to no anticoagulation for acute kidney injury patients at high risk of bleeding
por: Gao, Jianping, et al.
Publicado: (2019)

Recurrent early filter clotting in regional citrate anticoagulated continuous venovenous hemodialysis due to undetected antibodies to heparin-platelet factor 4 complexes
por: Slowinski, T, et al.
Publicado: (2010)

Regional citrate anticoagulation in high-volume continuous venovenous hemodialysis
por: Kalb, R, et al.
Publicado: (2011)

Regional citrate anticoagulation for continuous renal replacement therapy in newborns
por: Huang, Haixia, et al.
Publicado: (2023)

The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
por: Ma, Min, et al.
Publicado: (2022)

A prospective study on serum citrate levels and clinical correlations in patients receiving regional citrate anticoagulation
por: To, Harmony H M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ofivoibehdfhr2hj101babl6u4